Swallowing safety and efficacy with the Dr Jacqueline 13/CEN/109 Approve Waitemata DHB Intervention Swallow Expansion Device (SED) Allen Associate Professor Janet Subliminal Priming differences between Miss Caitlin Carter,Associate 13/CEN/11 Decline Observational people with, and without depression Aberhart Professor Janet Carter,Dr Ewald Neumann Zenith Technology Levonorgestrel 1 x 1.5 mg tablet Corporation Limited,Zenith 13/CEN/110 Approve bioequivalence study conducted under Dr Noelyn Hung Intervention Technology Corporation fasting conditions Limited Dr Penelope 13/CEN/111 Approve E-cigarette acceptability CCDHB,Dr Penelope Truman Observational Truman Auckland District Health Clinical Utility of Cognitive Screening Tools Dr April Board,cdhb,Lakes District 13/CEN/112 Approve Observational (CUTCOST) Clugston Health Board,Lakes District Health Board Testing biomarkers for diabetic Dr Renwick Professor Juliet 13/CEN/113 Decline Observational complications Dobson Gerrard A study to evaluate the efficacy, safety and tolerability of topically applied tretinoin Dr Marius 13/CEN/114 Approve formulated with TPM as an anti-acne David Appleton,Eileen Bisley Intervention Rademaker preparation in human subjects with acne vulgaris. A study to evaluate if the study drug refametinib works and is safe in patients 13/CEN/115 Approve Prof Ed Gane Auckland District Health Intervention with liver cancer carrying a specific gene mutation (RAS mutation). Filaggrin mutations in atopic dermatitis in Professor Peter 13/CEN/116 Decline Intervention Māori R. Hull Free lymph node transfer in the treatment Mr Winston 13/CEN/117 Approve Dr Shugg Jan COO Intervention of lymphoedema McEwan
13/CEN/109 Approve Swallowing safety and efficacy with the Swallow Expansion Device (SED) Dr Jacqueline Allen Waitemata DHB Intervention 13/CEN/11 Decline Subliminal Priming differences between people with, and without depression Miss Caitlin Aberhart Associate Professor Janet Carter,Associate Professor Janet Carter,Dr Ewald Neumann Observational 13/CEN/110 Approve Levonorgestrel 1 x 1.5 mg tablet bioequivalence study conducted under fasting conditions Dr Noelyn Hung Zenith Technology Corporation Limited,Zenith Technology Corporation Limited Intervention 13/CEN/111 Approve E-cigarette acceptability Dr Penelope Truman CCDHB,Dr Penelope Truman Observational 13/CEN/112 Approve Clinical Utility of Cognitive Screening Tools (CUTCOST) Dr April Clugston Auckland District Health Board,cdhb,Lakes District Health Board,Lakes District Health Board Observational 13/CEN/113 Decline Testing biomarkers for diabetic complications Dr Renwick Dobson Professor Juliet Gerrard Observational 13/CEN/114 Approve A study to evaluate the efficacy, safety and tolerability of topically applied tretinoin formulated with TPM as an anti-acne preparation in human subjects with acne vulgaris. Dr Marius Rademaker David Appleton,Eileen Bisley Intervention 13/CEN/115 Approve A study to evaluate if the study drug refametinib works and is safe in patients with liver cancer carrying a specific gene mutation (RAS mutation). Prof Ed Gane Auckland District Health Intervention 13/CEN/116 Decline Filaggrin mutations in atopic dermatitis in Māori Professor Peter R. Hull Intervention 13/CEN/117 Approve Free lymph node transfer in the treatment of lymphoedema Mr Winston McEwan Dr Shugg Jan COO Intervention
central-regional-ethics-committee-annual-report-2013.docx